Skip to main content

Table 2 Cox regression analysis, recurrence free cancer specific survival (n = 560 in the multiple analysis)

From: The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort

 

Simple analysis

Multiple analysis

 

HR

95% CI

p-value

HR

95% CI

p-value

Sex

      

Female

1

     

Male

1.16

0.81-1.67

0.41

   

Age, median 74

      

<74

1

     

≥74

1.14

0.80-1.64

0.47

   

T category

      

T3

1

  

1

  

T4

3.65

2.46-5.43

<0.0001

2.69

1.74-4.16

<0.0001

Malignancy grade

      

Medium + Low

1

  

1

  

High*

1.49

0.98-2.27

0.06

1.42

0.92-2.18

0.11

Localisation

      

Right

1

     

Left

1.12

0.78-1.60

0.54

   

Perforation

      

No

1

  

1

  

Yes

3.66

2.34-5.73

<0.0001

2.57

1.54-4.30

0.0003

Fixation

      

No

1

  

1

  

Yes

2.49

1.69-3.67

<0.0001

1.32

0.83-2.10

0.23

Lymph nodes

      

≥12

1

     

<12

0.85

0.59-1.22

0.37

   

Neuronal invasion

      

No

1

  

1

  

Yes

2.05

1.24-3.38

0.005

1.46

0.84-2.55

0.18

Vascular invasion

      

No

1

  

1

  

Yes

2.00

1.27-3.16

0.003

1.61

1.00-2.61

0.05

MSI status

      

MSI

1

     

MSS

1.39

0.90-2.15

0.14

   

miRNA-126

      

<median

1

  

1

  

>median

0.72

0.50-1.04

0.08

0.96

0.66-1.40

0.83

MVD

      

<median

1

     

>median

0.88

0.61-1.26

0.49

   
  1. HR: hazard ratio; CI: confidence interval; MSI: microsatellite instability; MSS: microsatelite stable; miRNA-126: microRNA-126; MVD: microvessel density.
  2. *Including mucinous and sigillocellular adenocarcinomas.
  3. Significant p-values are highlighted in bold.